Table 5 Results from Year 5 sample, mortality follow-up of up to 10 years
From: Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study
| Â | Hazards Ratio | 95% Confidence Interval |
|---|---|---|
Sex | Â | Â |
   Male | 1.36 | (1.12, 1.64) |
   Female | 1.00 |  |
Age | 1.09 | (1.07, 1.10) |
Body Mass Index | 1.01 | (0.98, 1.03) |
Education | Â | Â |
   < 12 Years | 1.24 | (0.96, 1.59) |
   12 Years | 1.10 | (0.90, 1.34) |
   > 12 Years | 1.00 |  |
Race | Â | Â |
   White | 1.00 |  |
   Black | 1.77 | (1.22, 2.56) |
Smoking Status | Â | Â |
   Former Smoker | 0.63 | (0.50, 0.80) |
   Intermittent Smoker | 0.85 | (0.64, 1.13) |
   Current Smoker | 1.00 |  |
Randomization Group | Â | Â |
   Intervention, Ipratroprium | 0.86 | (0.69, 1.07) |
   Intervention, Placebo | 0.91 | (0.74, 1.13) |
   Control | 1.00 |  |
Stage (Pre-bronchodilator)* | Â | Â |
   Stage 3 or 4 | 2.68 | (1.51, 4.75) |
   Stage 2 | 1.60 | (0.94, 2.69) |
   Stage 1 | 1.12 | (0.63, 1.98) |
   Restricted | 2.25 | (1.04, 4.86) |
   Normal | 1.00 |  |
Stage (Post-bronchodilator)* | Â | Â |
   Stage 3 or 4 | 2.46 | (1.63, 3.73) |
   Stage 2 | 1.11 | (0.82, 1.51) |
   Stage 1 | 0.74 | (0.52, 1.06) |
   Restricted | 1.36 | (0.74, 2.47) |
   Normal | 1.00 |  |